7Baggers

Pharvaris B.V
(NASDAQ:PHVS) 

PHVS stock logo

Pharvaris is a clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.

Founded: 2015
CEO: Berndt Modig  
Sector: Healthcare
Industry: Biotechnology
Healthcare
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-11-12 2025-06-30 2025-06-10 2025-05-13 2024-12-31 2024-11-13 2024-06-30 2024-06-11 2024-05-08 2023-12-31 2022-12-31 2022-06-30 2021-12-31 
                 
      notes
    		             
      research and development expenses
    		-29,814,908 -29,607,908 -98,563,529 -30,914,393 -31,199,929 -25,782,650 -23,067,934 -65,575,030 -18,513,016     
      general and administrative expenses
    		-9,849,591 -10,765,189 -47,124,638 -11,271,918 -13,892,105 -12,119,623 -11,314,067 -31,338,590 -9,798,843     
      total operating expenses
    		-39,664,499 -40,373,097 -145,688,167 -42,186,311 -45,092,034 -37,902,273 -34,382,001 -96,913,620 -28,311,859     
      finance income
    		2,345,995 -4,904,807 13,291,664 -3,851,845 11,570,287 -3,578,394 4,721,551  578,220   11,501,804  
      loss before income tax
    		-37,318,504 -45,277,904 -132,396,503 -46,038,156 -33,521,747 -41,480,667 -29,660,450 -99,826,263 -27,733,639     
      income taxes
    		181,469 -202,782  -302,667 -146,457.75 -230,091 -70,623  -285,117     
      net income
    		-37,137,035 -45,480,686 -134,221,527 -46,340,823 -34,760,940 -41,710,758 -29,731,073 -100,875,068 -28,018,756     
      yoy
    		6.84% 9.04% 351.45% -54.06% 24.06%         
      qoq
    		-18.35% -66.12% 189.64% 33.31% -16.66% 40.29% -70.53% 260.03%      
      other comprehensive loss
    		             
      items that may be reclassified to profit or loss:
    		             
      exchange gains arising on translation of foreign operations
    		-10,062 -261,162  -128,755 -10,832.75 -100,070 21,106  35,633     
      total comprehensive loss attributable to:
    		             
      equity holders of the company
    		-37,147,097 -45,741,848 -134,069,217 -46,469,578 -34,565,299 -41,810,828 -29,709,967 -100,932,942 -27,983,123     
      loss per share attributable to the equity holders of the company during the periods
    		             
      basic and diluted loss per share:
    		-0.6 -0.83  -0.85     -0.52     
      other comprehensive income
    		             
      income tax expense
    		  -1,825,024     -1,048,805      
      exchange gain arising on translation of foreign operations
    		  152,310     -57,874      
      basic and diluted loss per share
    		  -2.48  -0.64 -0.77 -0.55 -2.63      
      finance (expenses) income
    		       -2,912,643      
      operating income
    		             
      yoy
    		             
      qoq
    		             
      loss before tax
    		             
      loss for the period
    		             
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-11-12 2025-06-30 2025-06-10 2025-05-13 2024-12-31 2024-11-13 2024-06-30 2024-06-11 2024-05-08 2023-12-31 2023-11-02 2023-06-30 2023-06-01 2023-05-08 2022-12-31 2022-12-08 2022-06-30 2022-05-11 2021-12-31 2021-11-10 2021-07-30 2021-05-26 2020-12-31 
                             
        assets
      		                       
        non-current assets
      		                       
        property, plant and equipment
      		690,166 719,994 667,000 784,669 667,000 543,299 258,551 223,678 237,483 223,678 211,969 220,138 193,474 199,224 193,474 182,026 141,846 126,927 108,099 97,829 75,059 55,507 48,503 
        right of use assets
      		561,254 618,613 813,842 726,141 813,842 111,625 133,981 231,893 183,481 231,893 283,988 334,240 432,965 381,652 432,965 195,922 210,714 222,759 243,251 262,549 285,743   
        deferred tax assets
      		457,857 297,873 474,347 372,321 474,347 243,874 346,621 387,529 396,097 387,529 302,650 183,513 259,804 90,062 259,803 239,432 99,852 136,646 172,052 117,138 102,574 103,965 99,339 
        current assets
      		                       
        vat receivables
      		400,012                       
        other current assets
      		4,964,146 6,004,953 5,747,025 7,041,689 5,747,025 4,353,384 5,921,334 5,580,704 7,593,379 5,580,704 9,852,089 9,482,473 4,626,844 11,554,398 4,626,844 4,231,283 4,575,567 5,202,002 1,513,452 3,385,574 4,231,468 5,004,581 1,753,327 
        cash and cash equivalents
      		329,285,629 199,571,685 280,728,037 236,495,937 280,728,037 305,193,115 343,574,386 391,231,637 368,342,168 391,231,637 158,358,730 179,188,759 161,837,429 135,181,223 161,837,429 197,729,447 201,383,087 194,774,744 209,353,132 218,595,778 224,317,740 238,323,577 98,628,871 
        current tax receivable
      		2,537,137 2,065,568 2,486,680 2,060,162 2,486,680 2,084,773 1,095,589 615,538 479,528 615,538 21,154             
        total assets
      		338,896,201 209,810,326 291,374,765 248,064,041 291,374,765 313,175,462 351,845,766 398,694,465 377,595,207 398,694,465 169,339,425 189,743,422 167,732,984 147,800,641 167,732,983 202,982,265 206,742,994 201,132,092 212,090,064 223,091,235 229,725,349 244,028,946 101,099,618 
        equity and liabilities
      		                       
        equity
      		                       
        share capital
      		7,795,134 6,568,445 6,525,539 6,539,177 6,525,539 6,507,973 6,480,925 6,274,833 6,458,005 6,274,833 4,918,041 4,898,751 4,057,976 4,059,724 4,057,976 4,054,529 4,051,916 3,978,286 3,978,226 3,975,432 3,975,432 3,971,352 235,693 
        share premium
      		789,514,213 628,674,864 623,641,380 624,423,656 623,641,380 620,920,188 619,047,642 615,811,986 616,843,552 615,811,986 354,631,449 353,431,448 289,177,197 289,452,258 289,177,197 288,461,572 288,100,008 278,750,929 278,742,900 278,435,529 278,435,529 278,302,169 138,034,580 
        other reserves
      		47,569,667 44,289,200 39,711,103 43,072,189 39,711,103 36,166,919 31,965,648 27,894,796 29,863,658 27,894,796 26,180,298 24,249,330 20,169,459 22,475,537 20,169,459 17,415,183 14,713,625 11,721,354 9,774,416 8,095,502 5,757,542 4,041,324 1,979,875 
        currency translation reserve
      		-262,253 -252,191 137,726 8,971 137,726 -57,915 42,155 -14,584 21,049 -14,584 11,782 14,405 43,290 12,781 43,290 154,132 -54,483 34,608 25,928 -1,445 -2,690 -3,116 -4,365 
        accumulated loss
      		-532,376,121 -494,944,426 -402,255,007 -448,705,050 -402,255,007 -366,750,138 -324,767,645 -265,918,628 -294,017,604 -265,918,628 -232,612,994 -208,863,367 -164,188,892 -186,852,641 -164,188,892 -124,913,939 -116,237,411 -103,595,431 -87,568,401 -75,078,406 -65,937,407 -50,734,634 -44,459,954 
        total equity
      		312,240,640 184,335,892 267,760,741 225,338,943 267,760,741 296,787,027 332,768,725 384,048,403 359,168,660 384,048,403 153,128,576 173,730,567 149,259,030 129,147,659 149,259,030 185,171,477 190,573,655 190,889,746 204,953,069 215,426,612 222,228,406 235,577,095 95,785,829 
        long term liabilities
      		                       
        non-current lease liability
      		441,040 472,606 639,043 546,379 639,043 17,500 43,750 43,564 70,000 43,564 96,007 110,308 249,418 158,398 249,418 86,534 102,093 122,507 150,752 171,466 189,285   
        current liabilities
      		                       
        trade and other payables
      		2,548,047 4,859,249 4,562,900 4,225,946 4,562,900 4,195,854 2,968,446 2,909,725 5,558,487 2,909,725 4,434,246 5,277,616 6,685,080 8,030,293 6,685,080 7,095,858 4,168,955 3,356,266 2,490,572 3,846,476 3,343,006 4,315,827 846,952 
        accrued liabilities
      		22,679,349 19,400,357 17,588,407 17,164,137 17,588,407 12,075,642 15,857,612 11,067,510 12,149,527 11,067,510 11,485,255 10,240,917 10,890,749 9,883,925 10,890,749 10,131,060 8,981,038 6,533,027 4,270,082 3,646,681 3,964,652 4,136,024 4,466,837 
        current lease liability
      		137,617 161,544 222,427 194,599 222,427 99,439 96,628 195,341 120,461 195,341 195,341 228,120 187,404 228,120 187,404 112,287 110,772 101,832 99,432     
        current tax payable
      		849,508 580,678 601,247 594,037 601,247  110,605 429,922 528,072 429,922  155,894 461,303 352,246 461,302   128,714 126,157     
        total liabilities
      		26,655,561 25,474,434 23,614,024 22,725,098 23,614,024 16,388,435 19,077,041 14,646,062 18,426,547 14,646,062 16,210,849 16,012,855 18,473,954 18,652,982 18,473,953 17,810,788 16,169,339 10,242,346 7,136,995 7,664,623 7,496,943 8,451,851 5,313,789 
        total equity and liabilities
      		338,896,201 209,810,326 291,374,765 248,064,041 291,374,765 313,175,462 351,845,766 398,694,465 377,595,207 398,694,465 169,339,425 189,743,422 167,732,984 147,800,641 167,732,983 202,982,265 206,742,994 201,132,092 212,090,064 223,091,235 229,725,349 244,028,946 101,099,618 
        receivables
      		 531,640 457,834 583,122 457,834 645,392 515,304 423,486 363,071 423,486 308,845 334,299 382,468 394,082 382,468 404,155 331,928 669,014 700,079 632,367 712,765 541,316 569,578 
        current tax liability
      		               385,049 2,806,481       
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-11-12 2025-06-30 2025-05-13 2024-11-13 2024-06-30 2024-05-08 2023-11-02 2023-06-30 2023-05-08 2022-12-08 2022-06-30 2022-05-11 2021-11-10 2021-07-30 2021-05-26 
                       
          operating activities
        		               
          loss before tax
        		-128,634,564 -91,316,060 -46,038,156 -98,874,756 -57,394,089 -27,733,639 -67,826,310 -44,373,987 -22,570,292 -36,760,014 -25,868,281 -15,988,315 -30,299,824 -21,224,095 -6,024,288 
          non-cash adjustments to reconcile loss before tax to net cash flows from operations:
        		               
          share-based payment expense
        		14,512,568 9,625,030 4,127,912 11,369,994 6,288,303 2,400,867 8,185,156 5,299,814 2,582,887 8,133,588 5,089,777 1,946,938 6,207,308 3,869,348 2,096,610 
          depreciation expense
        		313,485 208,333 105,301 178,604 135,032 66,355 191,526 123,593 61,869 106,767 68,195 32,850 44,003 15,048 3,061 
          net foreign exchange loss
        		11,981,990 12,001,515 5,386,295 2,561,497 -3,146,528 -541,252  928,172 1,595,478  -14,971,998 -3,436,187 -7,837,250 -3,503,986 -5,905,895 
          finance income
        		-410,470 -438,896 -1,170,692 -4,127,865 -2,160,801 -55,968          
          changes in working capital:
        		               
          decrease in receivables
        		57,822  -125,287 -221,874 -91,786 60,447 73,623 48,169  295,924 368,151 31,065 -62,789 -143,187 28,262 
          increase in other current assets
        		1,543,852 -383,606 -1,294,663  -300,336 -2,012,674 -5,225,243 -4,855,629 -6,927,554   -3,275,589 -3,067,974  -4,463,880 
          increase trade and other payables
        		-3,938,399 422,029 -336,954 1,284,669 58,721 2,648,762 -2,250,834 -1,522,938        
          increase in accrued liabilities
        		5,089,500 942,596 -533,016 -361,382 3,690,913 935,123 237,109 -948,917 -1,101,550 5,787,859 4,609,866 1,963,578 163,657 481,628 652,900 
          income taxes
        		-80,522               
          received interest
        		443,862 462,559 1,183,396 4,094,083 2,120,352 60,171 111,694 83,384 53,712       
          net cash flows from operating activities
        		-99,120,876 -68,451,963 -38,471,605 -85,176,509 -51,914,977 -24,231,811 -69,240,196 -45,687,465 -25,204,785 -46,749,661 -31,568,574 -17,881,192 -32,096,567 -22,058,913 -10,199,606 
          investing activities
        		               
          purchase of property, plant and equipment
        		-163,081 -144,367 -161,003 -377,169 -70,844 -30,708 -61,604 -54,114 -19,038 -100,657 -49,739 -26,372 -61,494 -33,554 -10,065 
          net cash flows from investing activities
        		-163,081 -144,367 -161,003 -377,169 -70,844 -30,708 -61,604 -54,114 -19,038 -100,657 -49,739 -26,372 -61,494 -33,554 -10,065 
          financing activities
        		               
          proceeds from issue of shares
        		171,400,309 29,458 29,088 1,651,470 632,737 189,764 64,201,004 64,084,953  9,609,865 9,587,940 8,339 157,236,819 157,236,819 157,155,899 
          transaction costs on issue of shares
        		-10,911,884   592,000 592,968 659,039 -373,257 -210,473    -102,443 -12,925,547 -12,925,547 -13,154,360 
          payment of principal portion of lease liabilities
        		-152,697 -127,805 -104,535 -133,077 -107,239 -53,761 -165,852 -90,249 -56,752       
          net cash flows from financing activities
        		160,335,728 -98,347 -75,447 2,110,393 1,118,466 795,042 63,661,895   8,810,178 8,823,313 -110,126 144,290,697 144,306,260 144,001,539 
          net increase in cash and cash equivalents
        		61,051,771    -50,867,355   18,042,652  -38,040,140 -22,794,999 -18,017,690 112,132,636 122,213,793 133,791,868 
          cash and cash equivalents at the beginning of the period
        		280,728,037 280,728,037 280,728,037 391,231,637 391,231,637 391,231,637 161,837,429 161,837,429 161,837,429 209,353,132 209,353,132 209,353,132 98,628,871 98,628,871 98,628,871 
          effect of exchange rate changes
        		-12,494,179 -12,461,675 -5,524,045 -2,595,237 3,210,104 578,008 2,161,206 -691,322 -1,375,631 26,416,455 14,824,955 3,439,302 7,834,271 3,475,076 5,902,838 
          cash and cash equivalents at the end of the period
        		329,285,629 199,571,685 236,495,937 305,193,115 343,574,386 368,342,168 158,358,730 179,188,759 135,181,223 197,729,447 201,383,087 194,774,744 218,595,778 224,317,740 238,323,577 
          (increase) in receivables
        		 -73,806              
          income taxes received
        		 98,343 224,259             
          net decrease in cash and cash equivalents
        		 -68,694,677 -38,708,055 -83,443,285  -23,467,477 -5,639,905  -25,280,575       
          non-cash adjustments to reconcile loss before tax to net cash flows / used in operations:
        		               
          finance (income) costs
        		               
          decrease in other current assets
        		   1,271,056          -3,919,580  
          increase in trade and other payables
        		        1,215,762 4,605,286 1,678,383 854,291 2,723,748 2,367,811 3,500,664 
          income taxes paid
        		   -2,350,535 -1,114,758 -60,003 -830,568 -383,953 -2,270 -200,041      
          proceeds from issue of shares and pre-funded warrants
        		               
          transaction costs
        		         -726,367 -727,308     
          cash and cash equivalents at the beginning of the year
        		               
          cash and cash equivalents at the end of the year
        		               
          net foreign exchange gain
        		      -1,759,432   -26,492,975      
          finance expense
        		      -146,917 -85,173 -101,213       
          net cash flows from by financing activities
        		       63,784,231 -56,752       
          non-cash adjustments to reconcile loss before tax to net cash flows/used in operations :
        		               
          finance costs
        		         105,058 79,016  238,351 159,613 -87,040 
          paid interest
        		         -138,915 -58,463 -50,134 -177,640 -134,418  
          increase in receivables
        		        -11,614       
          (increase) in other current assets
        		         -2,192,198 -2,563,219     
          decrease in financial liability
        		         -73,320 -37,319     
          finance (income) / costs
        		           40,311    
          payment of lease liabilities
        		           -16,022 -20,575   
          decrease in accrued liabilities
        		               
          taxes paid
        		            -28,157 -27,095